Although LAC supplement is a simple and cost-effective adjuvant therapy used for the treatment of most neurological diseases, its therapeutic effect on BD is controversial (63)
Here we report the engineering and preclinical development of a bimodal molecule that integrates NMDA receptor antagonism with glucagon-like peptide-1 (GLP-1) receptor agonism to effectively reverse obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease
Studies have also reported that under the conditions of comparable glycemic control, liraglutide (1.2 mg/d) alone was more effective than liraglutide with metformin or metformin alone on lipid metabolism and cardiovascular protection [36]
A., Moses, K., Schwartz, R
A 2015 study in Beneficial Microbes found that C
Commercial insulin preparations differ in a number of ways, such as differences in the recombinant DNA production techniques, amino acid sequence, concentration, solubility, and the time of onset and duration of their biologic action